'''Enpiprazole''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]) is an [[anxiolytic]] [[drug]] of the [[phenylpiperazine]] group that was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA488|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=488–}}</ref><ref name="isbn0-113-22558-X">{{cite book | author = Bernan, British Pharmacopoeia Commission | title = British Approved Names 2002 | publisher = The Stationery Office | location = United Kingdom | year = 2002 | pages = 359 | isbn = 0-11-322558-X | oclc = | doi = | url = https://books.google.com/books?id=zruxjioUFngC&lpg=PA100&pg=PA100#v=onepage&q&f=false}}</ref> It produces anxiolytic-like effects in animals, though these effects appear to be biphasic and may reverse at high doses.<ref name="pmid12526">{{cite journal |vauthors=Murasaki M, Hara T, Oguchi T, Inami M, Ikeda Y | title = Action of enpiprazole on emotional behavior induced by hypothalamic stimulation in rats and cats | journal = Psychopharmacology | volume = 49 | issue = 3 | pages = 271–4 |date=September 1976 | pmid = 12526 | doi = 10.1007/BF00426829| url = }}</ref> It is known to produce [[ortho-chlorophenylpiperazine|''ortho''-chlorophenylpiperazine]] (oCPP) as a [[metabolite]].<ref name="Goodwin2004">{{cite book|author=B.L. Goodwin|title=Handbook of Biotransformations of Aromatic Compounds|url=https://books.google.com/books?id=luttauRomC8C&pg=SL3-PA124|date=10 November 2004|publisher=CRC Press|isbn=978-0-203-64196-5|pages=3–}}</ref>
